We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TCOM:NASDAQTrip.com Group Limited Analysis

Data as of 2026-05-04 - not real-time

$52.83

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Trip.com (TCOM) is trading around $52.8, comfortably above its 20‑day SMA of $53.1 but below the 50‑day SMA of $52.2, indicating a flat short‑term bias. The MACD histogram is modestly positive and the RSI sits near 49, suggesting limited momentum and a neutral trend. Support sits at $49.6 while resistance is near $55.7, and the stock has experienced a sharp 30‑day volatility of roughly 25%, with a beta close to 1, implying market‑aligned risk. On the fundamentals side, revenue grew 21% year‑over‑year, gross margins exceed 80%, and the trailing PE is just 7.6, placing the stock well below its DCF‑derived fair value of $172, which translates to a ~45% upside. Cash on hand ($71.9B) dwarfs debt ($31.6B) and the payout ratio is a modest 4.6%, making the 0.57% dividend appear sustainable. However, the company faces heightened regulatory scrutiny, highlighted by multiple securities‑fraud class‑action filings alleging antitrust misstatements, which have contributed to a recent 17% price drop.
Overall, the valuation metrics and cash strength support a buy view, but the ongoing legal risk and high volatility advise caution in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with limited upside in the next weeks
  • Neutral technical indicators (RSI, MACD) and high short‑term volatility
  • Pending securities‑fraud litigation creating near‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and high operating margins
  • Substantial upside to DCF fair value and low PE multiple
  • Sustainable dividend and ample cash cushion

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term undervaluation with ~45% upside to target price
  • Robust cash generation and low payout ratio supporting dividend growth
  • Potential resolution of regulatory issues and continued market share expansion in travel services

Key Metrics & Analysis

Financial Health

Revenue Growth20.80%
Profit Margin53.35%
P/E Ratio7.6
ROE21.13%
ROA3.87%
Debt/Equity18.32
P/B Ratio1.4
Op. Cash Flow$14.4B
Free Cash Flow$2.2B

Technical Analysis

TrendNeutral
RSI48.9
Support$49.62
Resistance$55.70
MA 20$53.12
MA 50$52.23
MA 200$64.43
MACDBullish
VolumeStable
Fear & Greed Index88.27

Valuation

Fair Value$172.33
Target Price$76.55
Upside/Downside44.91%
GradeUndervalued
TypeGrowth
Dividend Yield0.57%

Risk Assessment

Beta0.98
Volatility24.90%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.